Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity. / Wong, D F; Gjedde, A; Wagner, H N; Dannals, R F; Douglass, K H; Links, J M; Kuhar, M J.
In: Journal of Cerebral Blood Flow and Metabolism, Vol. 6, No. 2, 1986, p. 147-53.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Quantification of Neuroreceptors in the living human brain. II. Inhibition studies of receptor density and affinity.
AU - Wong, D F
AU - Gjedde, A
AU - Wagner, H N
AU - Dannals, R F
AU - Douglass, K H
AU - Links, J M
AU - Kuhar, M J
PY - 1986
Y1 - 1986
N2 - A method for estimating receptor density (Bmax) in the living human brain by positron emission tomography was exemplified by a ligand, 3-N-[11C]methylspiperone ([11C]NMSP), that binds to D2 dopamine receptors with high affinity. The ligand binds essentially irreversibly (i.e., with very little dissociation) to the receptors during the 2-h scanning period. Transfer constants were estimated at steady state. In a previous article, we presented a method for the determination of k3, the rate of binding of the labeled ligand. In the present work, we varied k3 by reducing the number of available receptors with a previously administered receptor blocking agent, haloperidol. We calculated a receptor density of 9.2 pmol g-1 in the caudate nucleus of four normal volunteers, and an inhibitory constant of haloperidol of 1.4 nM by comparing tracer accumulation in the absence and the presence of the blocking agent. The values agreed with measurements of NMSP receptor density and haloperidol inhibitory potency in vitro in brain homogenates from human autopsy material.
AB - A method for estimating receptor density (Bmax) in the living human brain by positron emission tomography was exemplified by a ligand, 3-N-[11C]methylspiperone ([11C]NMSP), that binds to D2 dopamine receptors with high affinity. The ligand binds essentially irreversibly (i.e., with very little dissociation) to the receptors during the 2-h scanning period. Transfer constants were estimated at steady state. In a previous article, we presented a method for the determination of k3, the rate of binding of the labeled ligand. In the present work, we varied k3 by reducing the number of available receptors with a previously administered receptor blocking agent, haloperidol. We calculated a receptor density of 9.2 pmol g-1 in the caudate nucleus of four normal volunteers, and an inhibitory constant of haloperidol of 1.4 nM by comparing tracer accumulation in the absence and the presence of the blocking agent. The values agreed with measurements of NMSP receptor density and haloperidol inhibitory potency in vitro in brain homogenates from human autopsy material.
M3 - Journal article
C2 - 2937795
VL - 6
SP - 147
EP - 153
JO - Journal of Cerebral Blood Flow and Metabolism
JF - Journal of Cerebral Blood Flow and Metabolism
SN - 0271-678X
IS - 2
ER -
ID: 14946193